Drug Database
CI

ciprofloxacin (Aceoto / Cetraxal / Cetraxal Otico)

✓ Approved

Laboratorios SALVAT · 小分子 · 小分子

什么是 ciprofloxacin?

ciprofloxacin 是一种小分子,由Laboratorios SALVAT研发。该药已获批,用于治疗相关适应症,给药途径:Others。

药物档案

商品名Aceoto, Cetraxal, Cetraxal Otico
公司Laboratorios SALVAT
药物类别小分子
给药途径Others
状态Approved

治疗适应症

ciprofloxacin 针对 2 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsOtitis externa✓ Approved
Ear and labyrinth disordersExternal ear inflammation✓ Approved

相关研究文献

PubMedBioorganic chemistry2026-06-13

Naphthalimide-mediated multitargeting antibacterial actions to enhance efficacy and broaden antibacterial spectrum of nitroimidazolyl ethylalcohols.

Wu Xin-Miao XM, Li Ling-Yun LY, Wu Xiao-Han XH, Wang Jin-Xin JX et al.

To combat the escalating challenge of bacterial resistance, a novel class of naphthalimide-mediated nitroimidazolyl ethylalcohols (NNEs) was developed. Most of the prepared NNEs showed potent antibacterial activities. Notably, nitrophenylamino NNE 37 g enhanced the activity of metronidazole against anaerobic bacteria and expanded its antibacterial spectrum to aerobic bacteria (MICs = 0.25-4 μg/mL), being superior to ciprofloxacin and ceftizoxime. Structure-activity relationship analysis suggested that the nitroimidazolyl ethylalcohol fragment was essential for activity, whereas chirality showed negligible effect on antibacterial efficacy. NNE 37 g also demonstrated low cytotoxicity, hemolysis, drug resistance and favorable plasma stability. Galleria mellonella infection model further demonstrated its more potent anti-MRSA efficacy in vivo than ciprofloxacin. Moreover, NNE 37 g displayed multitargeting antibacterial mechanisms, involving allosteric inhibition of PBP2a, DNA intercalation, and disruption of redox homeostasis via ROS/RNS overproduction, ultimately resulting in bacterial cell death. This series of studies provides a promising prospect for the development of naphthalimide-mediated nitroimidazolyl ethylalcohols as potential antibacterial candidates to tackle bacterial infections.

PMID 42284880
阅读全文 →
PubMedSpectrochimica acta. Part A, Molecular and biomolecular spectroscopy2026-06-13

Identification and content prediction of antibiotics in milk based on fluorescence hyperspectral technology.

Long Yuntao Y, Bian Yun Y, Song Feihu F, Jin Guangyuan G et al.

Antibiotic residues in milk affect the quality and safety of dairy products, which are crucial to the health of consumers and the sustainable development of the dairy industry. This study utilizes fluorescence hyperspectral imaging (F-HSI) technology in combination with machine learning algorithms for the rapid, nondestructive detection of quinolone antibiotics (ciprofloxacin, ofloxacin) and chloramphenicol antibiotics in milk. The results demonstrated that the MSC-whole-band-SVM and MSC-RF-SVM combination classification models performed the best, with accuracies of 100% for the calibration set and 97.5610% for the prediction set. The original spectrum-SPA+2D-COS-PLSR algorithm model was the best quantitative model for ciprofloxacin residue samples, with an R2 P of 0.88167 and an RMSEP of 0.030637. The MSC-RF + 2D-COS algorithm model was the best quantitative model for ofloxacin residue samples, with an R2 P of 0.89832 and an RMSEP of 0.030531. The SNV-RF + 2D-COS algorithm model was the best quantitative model for chloramphenicol residue samples, with an R2 P of 0.8755 and an RMSEP of 0.036625. These results indicate that F-HSI combined with machine learning can effectively identify and predict the type and concentration of antibiotic residues in milk, and further evaluation under regulatory standards and practical conditions may enhance understanding of its applicability.

PMID 42284864
阅读全文 →
PubMedScientific reports2026-06-13

Optimization of ciprofloxacin removal from aqueous solutions using the TiO2/Fe3O4/UV process and toxicity assessment via resazurin reduction test.

Ghaderpoori Mansour M, Yaghobi Maryam M, Azimi Faramarz F, Kamarehie Bahram B et al.

Ciprofloxacin (CIP) is a widespread environmental pollutant due to its high chemical stability and frequent presence in aquatic environments. Even at low concentrations, it poses serious risks to human health and ecosystems. This study aimed to optimize the photocatalytic degradation of CIP and evaluate the toxicity of the treated effluent from aqueous solutions. The experiments were conducted in batch mode using a 3 L photocatalytic reactor. Experimental optimization was performed using the Central Composite Design (CCD), considering pH, contact time, CIP concentration, and nanoparticle dose as variables. TiO2/Fe3O4 nanocomposites were synthesized via the sol-gel method. Their structure, morphology, and elemental composition were analyzed using Scanning Electron Microscopy (SEM), Fourier Transform Infrared Spectroscopy (FTIR), X-Ray Diffraction (XRD (and Energy Dispersive X-Ray Spectroscopy (EDX). CIP residual concentrations were measured using High-Performance Liquid Chromatography )HPLC( according to the experimental design. Effluent toxicity was assessed using a resazurin colorimetric assay based on Escherichia coli activity. The results of the study showed that the synthesized nanoparticles were spherical, with a homogeneous size distribution below 100 nm, smooth surface morphology, and no observable aggregation, indicating successful synthesis of structurally stable and well-dispersed nanoparticles. Based on the CCD model, the optimal conditions were a contact time of 67.50 min, pH 7.50, an initial CIP concentration of 1 mg/L, and a nanocomposite dose of 255 mg/L. Under these conditions, CIP removal reached approximately 95%. ANOVA indicated that a second-order regression model with a high coefficient of determination (R2 = 0.9895) best fit the data. The untreated CIP solution exhibited high toxicity toward E. coli, with a Half Maximal Effective Concentration (EC50) of 1.30 mg/L. After photocatalytic treatment, EC50, 100% mortality concentration, and No Observed Effect Concentration (NOEC) in the treated effluent were 1.37, 2.27, and 0.92 mg/L, respectively; the reduction in toxicity was statistically significant (p < 0.05). These results indicate that the synthesized TiO2/Fe3O4 nanocomposite, combined with UV-C ) power = 125 W, intensity = 20 mW/cm2, λmax = 254 nm) radiation, is an effective and stable method for treating wastewater contaminated with antibiotics. The integration of effluent toxicity assessment with experimental modeling (CCD and statistical analysis) represents a novel aspect of this study. This approach has the potential to be scaled up for large-scale environmental applications and to ensure compliance with effluent discharge standards. However, several limitations, including dependence on operational conditions, the formation of potentially toxic intermediate compounds, and challenges in scalability, require further investigation.

PMID 42286065
阅读全文 →
PubMedAnnals of hepatology2026-06-12

Secondary prophylaxis of SBP in cirrhosis: trimethoprim-sulfamethoxazole vs. ciprofloxacin in a propensity-matched cohort.

Osman Mohamad Mahdi MM, Sims Omar T OT, Chiang Dian J DJ

Spontaneous bacterial peritonitis (SBP1) is a common complication of cirrhosis. In the United States, inconsistent norfloxacin availability has shifted secondary SBP prophylaxis toward ciprofloxacin or trimethoprim-sulfamethoxazole (TMP-SMX2), but these agents have not been robustly compared head-to-head. We compared clinical outcomes among patients receiving TMP-SMX versus ciprofloxacin for secondary SBP prophylaxis. We conducted a multicenter retrospective cohort study using the TriNetX de-identified electronic health record network. Adults with cirrhosis (ICD-10 K74.6) and SBP (ICD-10 K65.2) from January 2013 to July 2021 were included. Index date was the first prescription for TMP-SMX (RxNorm 10829/10180) or ciprofloxacin (RxNorm 2551), with follow-up through July 11, 2024. Exclusions included prior exposure to the alternative agent, liver transplant, or end-stage renal disease. We performed 1:1 greedy nearest-neighbor propensity score matching (caliper 0.1) on demographics, comorbidities, and hepatic/renal laboratory variables. Primary outcomes were SBP recurrence and all-cause mortality; secondary outcomes included all-cause hospitalization, variceal bleeding, hepatic encephalopathy, and ascites. Cox proportional hazards models estimated hazard ratios (HRs). Among 31,011 patients (TMP-SMX 11,166; ciprofloxacin 19,845), 11,140 well-balanced matched pairs were analyzed. TMP-SMX was associated with lower SBP recurrence (HR 0.75, 95% CI 0.72-0.79) and all-cause mortality (HR 0.84, 95% CI 0.80-0.87; both p<0.0001). TMP-SMX also reduced risks of variceal bleeding (HR 0.81), hepatic encephalopathy (HR 0.79), and ascites (HR 0.86), while hospitalization was not significantly different. TMP-SMX was associated with significantly lower SBP recurrence and mortality than ciprofloxacin, supporting TMP-SMX as a potentially more effective secondary prophylaxis option pending randomized confirmation.

PMID 42276325
阅读全文 →
PubMedInvestigative ophthalmology & visual science2026-06-12

Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function.

Ebrahim Abdul Shukkur AS, Liu Li L, Carion Thomas W TW, Banga Loveleen L et al.

Previous studies have shown that adjunctive thymosin beta-4 (Tβ4) with ciprofloxacin reduces bacterial keratitis severity, enhances wound repair, and promotes a return to homeostasis. However, its impact on corneal nerves and visual function, two critical but often overlooked determinants of long-term outcomes, remains unexplored. The present study addresses this gap by evaluating whether adjunctive Tβ4 supports nerve regeneration and restores visual function after infection. Bacterial keratitis was induced in C57BL/6 mice by inoculating wounded corneas with Pseudomonas aeruginosa American Type Culture Collection strain 19660. Topical treatments (PBS, Tβ4 monotherapy, ciprofloxacin monotherapy, adjunctive Tβ4 + ciprofloxacin) were administered three times daily, starting 24 hours post infection. Ocular disease severity was assessed by clinical scoring. Visual recovery was evaluated by measuring visual acuity (cycle/degree) and contrast sensitivity (%). Corneal sensitivity testing assessed nerve function, while β-III tubulin immunofluorescence was used to visualize and quantify corneal nerves in flat mounts. Adjunctive Tβ4 + ciprofloxacin treatment markedly improved visual acuity and contrast sensitivity and significantly enhanced corneal sensitivity and nerve regeneration compared with PBS, Tβ4, and ciprofloxacin monotherapies. Combination therapy restored nerve density and architecture to levels comparable to those in uninfected controls. Adjunctive Tβ4 treatment promotes meaningful reparative outcomes, restoring both visual function and corneal nerve integrity during P. aeruginosa keratitis. By demonstrating that functional vision and nerve regeneration can be restored with combination therapy, this study highlights the importance of incorporating these end points into therapeutic evaluation and supports further development of Tβ4-based adjunctive strategies.

PMID 42283548
阅读全文 →
PubMedInternational journal of molecular sciences2026-06-12

Heterozygous Nonsense Mutation in the Nuclear Transport Factor KPNA7, a Maternal Factor Active in Embryonic Tissues, Causes Autosomal Dominant Otosclerosis.

Benteau Tammy T, Abdelfatah Nelly N, Griffin Anne A, Penney Cindy C et al.

Otosclerosis is a common cause of conductive hearing loss thought to result from dysregulated bone remodeling in the embryonic tissues of the globuli interossei. Both familial and sporadic cases have been reported. To date, 10 published OTSC loci and four genes (FOXL1 (OTSC11), SMARCA4 (OTSC12), MEPE, SERPINF1) have been identified in autosomal dominant families. Using a combined genetic and genomics approach in five affected siblings, we identified a nonsense mutation in Karyopherin subunit α7 (KPNA7, c.49C>T, p.R17X), the newest of the importin-α family of nuclear transporters. KPNA7 is a key maternal factor involved in the classical transport of NLS-containing cargo proteins, active during early embryonic cleavage events and zygotic genome activation. So far, 377 cargo proteins associated with KPNA7 have been identified. Recessive KPNA7 variants cause skeletal abnormalities, epilepsy, intellectual disabilities and preimplantation embryo arrest (PREMBA). A closer look at the OTSC genes reveals their involvement in endochondral ossification signaling pathways. We explore how KPNA7 haploinsufficiency in the embryonic tissues of the otic capsule may cause dysregulated bone remodeling. This study expands the phenotypic spectrum of KPNA7 and provides new insights into the pathobiology of otosclerosis.

PMID 42278511
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多ciprofloxacin